文献速递慢性肾脏病

游离对甲酚硫酸盐与非透析慢性肾脏病患者心血管结局关联最强

Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究在523例非透析CKD G1-G5期患者中比较五种蛋白结合尿毒症毒素的总浓度与游离浓度的预后价值,中位随访5.5年。多变量Cox回归校正后,仅游离对甲酚硫酸盐(pCS)与主要心血管终点独立相关(HR 1.39,95%CI 1.14-1.71,P=0.0014),且与内皮激活/损伤标志物ANGPT2和MMP-7相关,后者亦预测心血管结局。

要点

  • 游离pCS较总pCS及其他蛋白结合毒素与CKD心血管结局关联更强。
  • 游离pCS与ANGPT2、MMP-7等内皮激活/损伤标志物显著相关。
  • ANGPT2和MMP-7亦独立预测非透析CKD患者心血管结局。

核心结论

  • 在非透析CKD患者中,游离pCS是五种蛋白结合尿毒症毒素中与心血管结局关联最强者。
  • 游离pCS可能通过影响内皮功能发挥心血管毒性,该假说值得进一步探索。

研究设计与样本

  • 前瞻性队列研究,纳入523例非透析CKD G1-G5期患者,中位随访5.5年。

主要发现

  • 随访期间149例患者发生主要终点(致命或非致命心血管事件)。
  • 多变量Cox回归校正年龄、性别、收缩压、糖尿病和eGFR后,仅游离pCS与主要终点独立相关(HR 1.39,95%CI 1.14-1.71,P=0.0014)。
  • 游离pCS与ADAMTS13(r=-0.114,P<0.05)、ANGPT2(r=0.194,P<0.001)、MMP-7(r=0.238,P<0.001)和syndecan-1(r=0.235,P<0.001)相关。
  • 内皮激活/损伤标志物中,ANGPT2(HR 1.46,95%CI 1.25-1.70,P<0.0001)和MMP-7(HR 1.31,95%CI 1.08-1.59,P=0.0056)亦预测主要结局。

临床怎么用

  • 在非透析CKD患者中,游离pCS可能作为心血管风险分层的新型生物标志物。
  • 内皮激活/损伤标志物ANGPT2和MMP-7或可辅助评估CKD患者心血管风险。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several protein-bound uraemic toxins (PBUTs) have been associated with cardiovascular (CV) and all-cause mortality in chronic kidney disease (CKD) but the degree to which this is the case per individual PBUT and the pathophysiological mechanism have only partially been unraveled. METHODS: We compared the prognostic value of both total and free concentrations of five PBUTs [p-cresyl sulfate (pCS), p-cresyl glucuronide, indoxyl sulfate, indole acetic acid and hippuric acid] in a cohort of 523 patients with non-dialysis CKD Stages G1-G5. Patients were followed prospectively for the occurrence of a fatal or non-fatal CV event as the primary endpoint and a number of other major complications as secondary endpoints. In addition, association with and the prognostic value of nine markers of endothelial activation/damage was compared. RESULTS: After a median follow-up of 5.5 years, 149 patients developed the primary endpoint. In multivariate Cox regression models adjusted for age, sex, systolic blood pressure, diabetes mellitus and estimated glomerular filtration rate, and corrected for multiple testing, only free pCS was associated with the primary endpoint {hazard ratio [HR]1.39 [95% confidence interval (CI) 1.14-1.71]; P = 0.0014}. Free pCS also correlated with a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (r = -0.114, P < 0.05), angiopoietin-2 (ANGPT2) (r = 0.194, P < 0.001), matrix metallopeptidase 7 (MMP-7; (r = 0.238, P < 0.001) and syndecan 1 (r = 0.235, P < 0.001). Of these markers of endothelial activation/damage, ANGPT2 [HR 1.46 (95% CI 1.25-1.70); P < 0.0001] and MMP-7 [HR 1.31 (95% CI 1.08-1.59); P = 0.0056] were also predictive of the primary outcome. CONCLUSIONS: Among PBUTs, free pCS shows the highest association with CV outcome in non-dialysed patients with CKD. Two markers of endothelial activation/damage that were significantly correlated with free pCS, ANGPT2 and MMP-7 were also associated with CV outcome. The hypothesis that free pCS exerts its CV toxic effects by an adverse effect on endothelial function deserves further exploration.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Glorieux G, Vanholder R, Van Biesen W, et al. Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease. Nephrol Dial Transplant. 2021. PMID: 33508125. doi:10.1093/ndt/gfab004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。